Skip to content

Research on the clinical mechanisms of individualized Traditional Chinese Medicine treatment for abdominal obesity

Research on the clinical mechanisms of individualized Traditional Chinese Medicine treatment for abdominal obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002134
Enrollment
Unknown
Registered
2025-11-08
Start date
2025-11-15
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity

Interventions

control grop:Acupuncture + lifestyle intervention
Experimental group:lifestyle intervention + combined external therapies

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets diagnostic criteria for abdominal obesity; (2) Aged 18–65 years, male or female; (3) Patients who voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary obesity caused by medications, surgery, endocrine factors, etc.; (2) Patients with severe hepatic or renal impairment, cachexia, cardiovascular or cerebrovascular events, or psychiatric disorders; (3) Pregnant or lactating women; (4) Individuals who have taken medications known to affect weight or appetite within the past 3 months, such as weight-loss drugs, corticosteroids, antidepressants, hypoglycemic agents, etc.; or those with plans to quit smoking or drinking; (5) Patients who have participated in other acupuncture treatments or studies within the past 3 months; (6) Patients with contraindications to acupuncture, such as severe allergies, bleeding disorders, or severe infections. (5) Patients who have participated in other acupuncture treatments or studies within the past 3 months; (6) Individuals with skin lesions at the intervention site or those with metal allergies; (7) Participants unable to cooperate or adhere to the intervention and follow-up requirements.

Design outcomes

Primary

MeasureTime frame
Abdominal fat content;

Secondary

MeasureTime frame
Gut Microbiome Metagenome;Metabolomics Analysis;magnetoencephalography;

Countries

China

Contacts

Public ContactLiang Cui-mei

Dongfang Hospital Beijing University of Chinese Medicine

dfzhenjiulcm@126.com18511284813

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026